Protalix Biotherapeutics Inc (PLX) — Financial Flexibility Index
Protalix Biotherapeutics Inc (PLX) has a Financial Flexibility Index of 0.10x as of December 2025. Free cash flow of $3.27 Million (operating CF $2.03 Million minus capex $1.24 Million) represents 0% of total liabilities ($34.12 Million). Check how strategically is Protalix Biotherapeutics Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Protalix Biotherapeutics Inc Financial Flexibility Index (1996–2025)
Historical Financial Flexibility Index trend for Protalix Biotherapeutics Inc across 30 annual periods. See Protalix Biotherapeutics Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Protalix Biotherapeutics Inc (1996–2025)
Year-by-year free cash flow to debt coverage for Protalix Biotherapeutics Inc. For the full company profile including market capitalisation, see Protalix Biotherapeutics Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.30x | $-10.36 Million | $-11.99 Million | $34.12 Million | ▼ -192.1% |
| 2024 | 0.33x | $9.96 Million | $8.67 Million | $30.21 Million | ▲ +10020.3% |
| 2023 | 0.00x | $-169.00K | $-1.32 Million | $50.87 Million | ▲ +99.1% |
| 2022 | -0.37x | $-24.37 Million | $-25.00 Million | $66.43 Million | ▼ -231.3% |
| 2021 | -0.11x | $-8.83 Million | $-10.29 Million | $79.70 Million | ▲ +58.7% |
| 2020 | -0.27x | $-25.45 Million | $-26.11 Million | $94.97 Million | ▼ -65.6% |
| 2019 | -0.16x | $-18.73 Million | $-19.36 Million | $115.71 Million | ▼ -161.6% |
| 2018 | -0.06x | $-7.06 Million | $-7.74 Million | $114.01 Million | ▲ +29.0% |
| 2017 | -0.09x | $-9.02 Million | $-9.99 Million | $103.51 Million | ▲ +74.3% |
| 2016 | -0.34x | $-31.25 Million | $-32.10 Million | $92.20 Million | ▼ -22.9% |
| 2015 | -0.28x | $-23.82 Million | $-24.28 Million | $86.38 Million | ▼ -29.7% |
| 2014 | -0.21x | $-28.50 Million | $-29.28 Million | $134.07 Million | ▼ -3.7% |
| 2013 | -0.21x | $-28.76 Million | $-30.65 Million | $140.28 Million | ▼ -722.7% |
| 2012 | 0.03x | $2.70 Million | $635.00K | $82.08 Million | ▲ +114.4% |
| 2011 | -0.23x | $-17.86 Million | $-23.57 Million | $77.88 Million | ▲ +43.0% |
| 2010 | -0.40x | $-30.61 Million | $-38.46 Million | $76.05 Million | ▼ -165.8% |
| 2009 | 0.61x | $50.65 Million | $44.45 Million | $82.79 Million | ▲ +131.3% |
| 2008 | -1.96x | $-12.64 Million | $-16.02 Million | $6.46 Million | ▼ -7.3% |
| 2007 | -1.82x | $-8.11 Million | $-10.45 Million | $4.45 Million | ▼ -16.0% |
| 2006 | -1.57x | $-4.25 Million | $-5.09 Million | $2.70 Million | ▼ -58.1% |
| 2005 | -0.99x | $-72.47K | $-72.47K | $72.93K | ▲ +58.3% |
| 2004 | -2.39x | $-168.12K | $-168.12K | $70.47K | ▼ -37.6% |
| 2003 | -1.73x | $-136.68K | $-136.68K | $78.82K | ▲ +6.5% |
| 2002 | -1.85x | $-146.59K | $-146.59K | $79.07K | ▲ +81.9% |
| 2001 | -10.22x | $-789.43K | $-789.43K | $77.28K | ▼ -10683.7% |
| 2000 | -0.09x | $-53.11K | $-53.11K | $560.61K | ▲ +96.8% |
| 1999 | -3.00x | $-1.38 Million | $-1.41 Million | $459.36K | ▼ -453.1% |
| 1998 | -0.54x | $-769.54K | $-909.52K | $1.42 Million | ▼ -1534.4% |
| 1997 | -0.03x | $-247.92K | $-247.92K | $7.47 Million | ▼ -500.7% |
| 1996 | -0.01x | $-40.57K | $-40.57K | $7.34 Million | — |